Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Quality Systems Guidance Uses Manufacturing Consent Decrees As Model

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA expects the draft guidance will pave the way toward revising the GMP regulations. The agency plans to apply its quality systems initiative to several internal areas including warning letters and recalls.

You may also be interested in...



FDA Quality Systems Guidance Suggests "Trending" For Batch Testing

Monitoring for trends allows for detection of potential problems "as early as possible," FDA says. The draft guidance, released as part of FDA's GMP initiative, organizes the quality systems model into four components: management responsibilities, resources, manufacturing operations and evaluation activities.

FDA Quality Systems Guidance Suggests "Trending" For Batch Testing

Monitoring for trends allows for detection of potential problems "as early as possible," FDA says. The draft guidance, released as part of FDA's GMP initiative, organizes the quality systems model into four components: management responsibilities, resources, manufacturing operations and evaluation activities.

FDA Good Manufacturing Practices Initiative Report Slated For October

GMP initiative report will include final guidance on process analytical technologies and aseptic processing, as well as draft guidance on the use of quality systems and computerized systems in clinical trials. The release will also contain "white paper" on prioritizing manufacturing sites for inspections.

Topics

UsernamePublicRestriction

Register

MT125529

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel